drugset / Trial / NCT03849287

Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults

NCT03849287

Phase 1 Unknown 36 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The object of clinical trial is to investigate the pharmacokinetics and safety compared to CKD-333 and co-administration CKD-330, D090 under fasting condition in healthy male adults.

Timeline

Start
2019-02-25
Primary completion
2019-03-29
Completion
2019-04-06

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-330 Unknown
Subject CKD-333 Unknown
Subject D090 Unknown